Chromosomal Gain of 3q and Loss of 11q Often Associated with Nodal Metastasis in Early Stage Cervical Squamous Cell Carcinoma

Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer

10.1054/bjoc.2000.1509 · 2000

Genomic changes and HPV type in cervical carcinoma

10.1046/j.1525-1373.2000.22345.x · 2000

Amplification at 9p in cervical carcinoma by comparative genomic hybridization

10.1155/2001/174645 · 2001

Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression

10.1002/gcc.1215 · 2002

Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma

10.1186/1471-2407-4-5 · 2004

Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas

10.1016/j.cancergencyto.2004.06.002 · 2005

Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes

10.1002/gcc.20418 · 2007

Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features

10.1016/s0046-8177(98)90117-4 · 1998

Allelic loss and prognosis in carcinoma of the uterine cervix

10.1002/(sici)1097-0215(19980821)79:4<411::aid-ijc17>3.0.co;2-7 · 1998

Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma

10.1016/s0165-4608(01)00510-6 · 2001

Genomic deletion and p53 inactivation in cervical carcinoma

10.1002/(sici)1097-0215(19970717)72:2<270::aid-ijc12>3.0.co;2-k · 1997

HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA

10.1002/(sici)1097-0215(19980119)75:2<199::aid-ijc6>3.0.co;2-p · 1998

Monoclonality and surface lesion-specific microsatellite alterations in premalignant and malignant neoplasia of uterine cervix: a local field effect of genomic instability and clonal evolution

10.1002/(sici)1098-2264(199902)24:2<127::aid-gcc5>3.0.co;2-8 · 1999

Prognostic factors in patients with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy

1998

The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy

10.1006/gyno.1999.5527 · 1999

Molecular cytogenetics of ovarian granulosa cell tumors by comparative genomic hybridization

10.1016/j.ygyno.2004.12.014 · 2005

Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals

10.1002/(sici)1097-0320(19980301)31:3<163::aid-cyto3>3.0.co;2-m · 1998

Loss of hetero-zygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24

10.1073/pnas.91.15.6953 · 1994

Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer

2000

A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13

10.1016/j.ygeno.2005.02.014 · 2005

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia

10.1093/jnci/djh031 · 2004

Identification of chromosomal alterations important in the development of cervical intraepithelial neoplasia and invasive carcinoma using alignment of DNA microarray data

10.1016/j.ygyno.2006.03.020 · 2006

Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma

10.1186/1471-2407-5-77 · 2005

Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer

10.1158/0008-5472.can-04-4112 · 2005

Targeting onco-genes to improve breast cancer chemotherapy

10.1158/0008-5472.can-05-4288 · 2006

Genetic alterations accumulate during cervical tumorigenesis and indicate a common origin for multifocal lesions

1997

Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma

1997

Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression

10.1038/sj.onc.1206432 · 2003

Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix

10.1038/bjc.1998.33 · 1998

Common fragile sites are preferential targets for HPV16 integrations in cervical tumors

10.1038/sj.onc.1206170 · 2003

Natural history of HLA expression during tumour development

10.1016/0167-5699(93)90264-l · 1993